Never before has health informatics played a greater role in public health than during the COVID-19 pandemic. While the Health IT industry is certainly challenged due to the overall disruption to the healthcare system, the pandemic undoubtedly underscores the opportunity and importance of health informatics, such as telehealth, remote patient monitoring, patient engagement, AI-based drug discovery, precision medicine, and clinical decision support, but nowhere more pressing than the fields of
Read More
Drug Discovery | Pharma |News, Analysis, Insights - HIT Consultant
Exscientia to Screen 15,000 Drugs in Search for Coronavirus Treatment
What You Should Know:
- Exscientia announced a joint transatlantic initiative with Diamond Light Source, the UK's national synchrotron facility and Calibr, a division of Scripps Research (USA), to screen nearly every known approved and investigational drug against key COVID-19 drug targets to progress compounds that could rapidly become viable drugs for the rapid treatment of the coronavirus.
- Exscientia has gained access to Calibr’s world’s leading collection of 15,000 clinically-ready
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
Chilmark Research: The Promise of AI & ML in Healthcare Report
What You Need to Know:
- New Chilmark Research report reveals artificial intelligence and machine learning (AI/ML) technologies are capturing the imagination of investors and healthcare organizations—and are poised to expand healthcare frontiers.
- The latest report evaluates over 120 commercial AI/ML solutions in healthcare, explores future opportunities, and assesses obstacles to adoption at scale.
Interest and investment in healthcare AI/ML tools
is booming with approximately
Read More
The Many Faces of AI in Clinical Trials
AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs.
The
Read More
Rock Health: 3 Central Themes Driving Digital Health Consumer Adoption
- Rock Health and the Stanford Center for Digital Health release their findings from the 2019 Consumer Adoption Survey. - In 2019, overall consumer adoption of digital health leveled off in 2019 near the 2018 high water mark. - Findings reveal consumer-clinician dialogue and transparency around data collection and sharing will be central to the growth of digital technology in healthcare.Digital health consumer adoption has leveled off in what appears to a slight moderation of digital health
Read More
BioSymetrics Launches New AI Capability to Improve Patient Outcomes
- First biomedical machine learning framework BioSymetrics introduces a new component that enables users to reduce bias, increase speed to market and improve patient outcomes.
- Augusta Architect enables data scientists in hospitals, healthcare systems, and pharmaceutical companies to perform fast, effective data pre-processing and ML.
- New component has a simple syntax that allows users to quickly process and integrate multiple, diverse datatypes and run or compare multiple ML
Read More
Partners HealthCare Launches $80M Investment Funds Towards AI & Digital Translation
- Partners HealthCare launches two new investment funds aimed at addressing the lack of translational funding in pre-clinical life sciences, Artificial Intelligence (AI) and digital technology development. - The Partners HealthCare Artificial Intelligence and Digital Translation Fund (AIDIF) has an initial funding of $30M over five years and the Translational Innovation Fund (TIF) has funding of $50M over six years.Partners HealthCare today announced the creation of two new investment venture
Read More
Healx Nabs $56M to Expand AI-Driven Drug Discovery Platform for Rare Diseases
- UK startup Healx lands $56M, led by Atomico to build an AI-driven clinical-stage portfolio for rare diseases, including treatments for fragile X syndrome, the leading genetic cause of autism.
- Healx’s Rare Treatment Accelerator program is a new initiative launched in close partnership with patient communities to identify clinic-ready treatments for rare diseases within 24 months.
Healx, a Cambridge, England-based AI-powered and patient-inspired technology company specializing in
Read More
Life Image, Graticule Partner to Help Biopharma Accelerate Drug Development
- Life Image partners with Graticule to help biopharma realize the full potential of advanced data in real-world evidence programs.
- Partnership combines Life Image’s global medical evidence network specializing in imaging data with Graticule’s deep expertise applying advanced data to high-value use cases.
Life Image, the world’s largest medical evidence network for clinical and imaging data has announced a new partnership with Graticule to help life sciences companies accelerate drug
Read More
